Whether a high-dose influenza vaccine is associated with a benefit in reducing CP events.
Mainz Biomed to Showcase ColoAlert® at Leading Global Healthcare Event, MEDICA – Biotech Investments
Issuer: Mainz BioMed N.V. / Key word(s): Conference 07.11.2023 / 14:01 CET/CEST The issuer is solely responsible for the content of this announcement. Mainz Biomed